Form D · Other Health Care
Fresenius Medical Care Obetz, LLC
Waltham, MA · CIK 0001950262
Offering snapshot reported Oct 12, 2022 · SEC filing
- Reported sold
- $2.67M Offering amount: $2.67M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $241K Reported outside-investor minimum
- First sale
- Oct 6, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 12, 2022 | Initial | $2,674,765 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-461444
Source: Form D, filed Oct 12, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Bitter | Director |
| Pamela Gray | Director |
| Trevor Halliday | Director |
| Melissa Hosey | Director |
| Brian Mussio | Director |
| Kevin O'reilly | Director |
| Katherine Sarisen | Director |
| Jason Schultz | Director |
| Ryan M. Valle | Director |
| Christine Wehrenberg | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Fresenius Medical Care North America 920 Winter Street
Waltham, MA, 02451
Waltham, MA, 02451